Publication | Open Access
Pemetrexed Plus Platinum for Patients With Advanced Non-small Cell Lung Cancer and Interstitial Lung Disease
16
Citations
18
References
2019
Year
The treatment with pemetrexed plus platinum has a high risk of AE-ILD in patients with advanced nonsquamous NSCLC and preexisting ILD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1